The New Product Development team at Vero Biotech is responsible for the conceptualization, design, and advancement of innovative inhaled nitric oxide (NO) delivery systems. Their multidisciplinary approach emphasizes research, clinical validation, and the integration of cutting-edge automation technologies to bring new cardiopulmonary therapies from ideation to market, addressing critical patient needs.
View all